BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Borah NA, Reddy MM. Aurora Kinase B Inhibition: A Potential Therapeutic Strategy for Cancer. Molecules 2021;26:1981. [PMID: 33915740 DOI: 10.3390/molecules26071981] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 20.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen L, Song Y, Hou T, Li X, Cheng L, Li Y, Xing Y. Circ_0004087 interaction with SND1 promotes docetaxel resistance in prostate cancer by boosting the mitosis error correction mechanism. J Exp Clin Cancer Res 2022;41:194. [DOI: 10.1186/s13046-022-02404-3] [Reference Citation Analysis]
2 Song J, Zhou Y, Yakymovych I, Schmidt A, Li C, Heldin C, Landström M. The ubiquitin-ligase TRAF6 and TGFβ type I receptor form a complex with Aurora kinase B contributing to mitotic progression and cytokinesis in cancer cells. eBioMedicine 2022;82:104155. [DOI: 10.1016/j.ebiom.2022.104155] [Reference Citation Analysis]
3 Bong IPN, Ng CC, Othman N, Esa E. Gene expression profiling and in vitro functional studies reveal RAD54L as a potential therapeutic target in multiple myeloma. Genes Genomics 2022;44:957-66. [PMID: 35689754 DOI: 10.1007/s13258-022-01272-7] [Reference Citation Analysis]
4 Wang H, Chi L, Yu F, Dai H, Si X, Gao C, Wang Z, Liu L, Zheng J, Ke Y, Liu H, Zhang Q. The overview of Mitogen-activated extracellular signal-regulated kinase (MEK)-based dual inhibitor in the treatment of cancers. Bioorg Med Chem 2022;70:116922. [PMID: 35849914 DOI: 10.1016/j.bmc.2022.116922] [Reference Citation Analysis]
5 Rybin MJ, Laverde-paz MJ, Suter RK, Affer M, Ayad NG, Feng Y, Zeier Z. A dual aurora and lim kinase inhibitor reduces glioblastoma proliferation and invasion. Bioorganic & Medicinal Chemistry Letters 2022;61:128614. [DOI: 10.1016/j.bmcl.2022.128614] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Roth A, Gihring A, Bischof J, Pan L, Oswald F, Knippschild U. CK1 Is a Druggable Regulator of Microtubule Dynamics and Microtubule-Associated Processes. Cancers 2022;14:1345. [DOI: 10.3390/cancers14051345] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Liu D, Wang Z, Zhong L, Xie C, Huang X, Zhi Y, Zhang Y, Liang J, Shi Z, Huang J, Zhang S, Zhang J, Ding F, Raza F. Targets and Potential Mechanism of Scutellaria baicalensis in Treatment of Primary Hepatocellular Carcinoma Based on Bioinformatics Analysis. Journal of Oncology 2022;2022:1-19. [DOI: 10.1155/2022/8762717] [Reference Citation Analysis]
8 Henriques-Pons A, Beghini DG, Silva VDS, Iwao Horita S, da Silva FAB. Pulmonary Mesenchymal Stem Cells in Mild Cases of COVID-19 Are Dedicated to Proliferation; In Severe Cases, They Control Inflammation, Make Cell Dispersion, and Tissue Regeneration. Front Immunol 2021;12:780900. [PMID: 35095855 DOI: 10.3389/fimmu.2021.780900] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
9 Liu M, Li Y, Zhang C, Zhang Q. Role of aurora kinase B in regulating resistance to paclitaxel in breast cancer cells. Hum Cell 2022. [PMID: 35088239 DOI: 10.1007/s13577-022-00675-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Baltzer S, Bulatov T, Schmied C, Krämer A, Berger BT, Oder A, Walker-Gray R, Kuschke C, Zühlke K, Eichhorst J, Lehmann M, Knapp S, Weston J, von Kries JP, Süssmuth RD, Klussmann E. Aurora Kinase A Is Involved in Controlling the Localization of Aquaporin-2 in Renal Principal Cells. Int J Mol Sci 2022;23:763. [PMID: 35054947 DOI: 10.3390/ijms23020763] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Bhatt H, Vishwakarma K, Shaw S. The retroactive and future potentials of Aurora kinases in the treatment of cancer. Protein Kinase Inhibitors 2022. [DOI: 10.1016/b978-0-323-91287-7.00016-8] [Reference Citation Analysis]
12 Varshney N, Rani A, Kashyap D, Tiwari D, Jha HC. Aurora kinase: An emerging potential target in therapeutics. Protein Kinase Inhibitors 2022. [DOI: 10.1016/b978-0-323-91287-7.00028-4] [Reference Citation Analysis]
13 Dokla EME, Abdel-Aziz AK, Milik SN, Mahmoud AH, Saadeldin MK, McPhillie MJ, Minucci S, Abouzid KAM. Indolin-2-one derivatives as selective Aurora B kinase inhibitors targeting breast cancer. Bioorg Chem 2021;117:105451. [PMID: 34736137 DOI: 10.1016/j.bioorg.2021.105451] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Sradhanjali S, Rout P, Tripathy D, Kaliki S, Rath S, Modak R, Mittal R, Chowdary TK, Reddy MM. The Oncogene MYCN Modulates Glycolytic and Invasive Genes to Enhance Cell Viability and Migration in Human Retinoblastoma. Cancers (Basel) 2021;13:5248. [PMID: 34680394 DOI: 10.3390/cancers13205248] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Ashraf S, Ranaghan KE, Woods CJ, Mulholland AJ, Ul-Haq Z. Exploration of the structural requirements of Aurora Kinase B inhibitors by a combined QSAR, modelling and molecular simulation approach. Sci Rep 2021;11:18707. [PMID: 34548506 DOI: 10.1038/s41598-021-97368-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Matthews HK, Bertoli C, de Bruin RAM. Cell cycle control in cancer. Nat Rev Mol Cell Biol 2021. [PMID: 34508254 DOI: 10.1038/s41580-021-00404-3] [Cited by in Crossref: 94] [Cited by in F6Publishing: 118] [Article Influence: 94.0] [Reference Citation Analysis]
17 Prasher P, Sharma M. Medicinal chemistry of pyrophosphate mimics: A mini review. Drug Dev Res 2021. [PMID: 34506652 DOI: 10.1002/ddr.21877] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Ahmed A, Shamsi A, Mohammad T, Hasan GM, Islam A, Hassan MI. Aurora B kinase: a potential drug target for cancer therapy. J Cancer Res Clin Oncol 2021;147:2187-98. [PMID: 34047821 DOI: 10.1007/s00432-021-03669-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]